Author details

Full Name

Silke Stertz

Affiliation

Institute of Medical Virology, University of Zurich

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36537693	Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus Inactivation.	Environ Sci Technol	2023
37594288	Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MS.	mSphere	2023
37819131	The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.	J Virol	2023
35081340	Phosphoproteomic profiling of influenza virus entry reveals infection-triggered filopodia induction counteracted by dynamic cortactin phosphorylation.	Cell Rep	2022
35766385	Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.	ACS Infect Dis	2022
35535160	Unraveling virus-induced cellular signaling cascades by label-free quantitative phosphoproteomics.	STAR Protoc	2022
35867415	Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.	Microbiol Spectr	2022
36037391	Expiratory aerosol pH is determined by indoor room trace gases and particle size.	Proc Natl Acad Sci U S A	2022
35320721	Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.	Cell Rep	2022
34083772	An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.	Nat Nanotechnol	2021
33882122	IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.	J Exp Med	2021
33760807	SARS-CoV-2 variants reveal features critical for replication in primary human cells.	PLoS Biol	2021
33757684	Interferon system deficiencies exacerbating severe pandemic virus infections.	Trends Microbiol	2021
33838498	Entry of influenza A virus into host cells - recent progress and remaining challenges.	Curr Opin Virol	2021
32152316	TIGIT limits immune pathology during viral infections.	Nat Commun	2020
31964943	Antiviral potential of 3'-sialyllactose- and 6'-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses.	Sci Rep	2020
31776280	Breaking the Convention: Sialoglycan Variants, Coreceptors, and Alternative Receptors for Influenza A Virus Entry.	J Virol	2020
32913009	Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.	mBio	2020
32848003	Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.	mSphere	2020
30787439	MHC class II proteins mediate cross-species entry of bat influenza viruses.	Nature	2019
31363119	Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation.	Nat Commun	2019
28643205	Role of Host Genes in Influenza Virus Replication.	Curr Top Microbiol Immunol	2018
30206219	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target.	Nat Commun	2018
28369159	Context-based retrieval of functional modules in protein-protein interaction networks.	Brief Bioinform	2018
29493494	A novel mutation in the neuraminidase gene of the 2009 pandemic H1N1 influenza A virus confers multidrug resistance.	J Gen Virol	2018
28819179	Identification of Polo-like kinases as potential novel drug targets for influenza A virus.	Sci Rep	2017
27449792	Late stages of the influenza A virus replication cycle-a tight interplay between virus and host.	J Gen Virol	2016
27613601	Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.	BMC Genomics	2016
25320322	Swine interferon-inducible transmembrane proteins potently inhibit influenza A virus replication.	J Virol	2015
26575457	Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry.	J Vis Exp	2015
26651948	Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.	Cell Host Microbe	2015
26112615	Recent strategies and progress in identifying host factors involved in virus replication.	Curr Opin Microbiol	2015
26060270	Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.	mBio	2015
25984567	A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein.	ACS Infect Dis	2015
25657216	Correction for lanz et Al., Swine interferon-inducible transmembrane proteins potently inhibit influenza a virus replication.	J Virol	2015
24225499	Entry of influenza A virus: host factors and antiviral targets.	J Gen Virol	2014
25031340	Prolidase is required for early trafficking events during influenza A virus entry.	J Virol	2014
23487453	Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.	J Virol	2013
23926347	Emergence of a C-terminal seven-amino-acid elongation of NS1 in around 1950 conferred a minor growth advantage to former seasonal influenza A viruses.	J Virol	2013
23720581	Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.	Sci Transl Med	2013
21276872	Uncovering the global host cell requirements for influenza virus replication via RNAi screening.	Microbes Infect	2011
20027183	Human host factors required for influenza virus replication.	Nature	2010
20739532	Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.	J Virol	2010
20975689	Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.	Nat Commun	2010
20126449	Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.	PLoS Pathog	2010
18199636	Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.	J Virol	2008
17210170	The intracellular sites of early replication and budding of SARS-coronavirus.	Virology	2007
17970694	The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.	J Interferon Cytokine Res	2007
18062906	The Mx GTPase family of interferon-induced antiviral proteins.	Microbes Infect	2007
17307214	Interferon-induced inhibition of parainfluenza virus type 5; the roles of MxA, PKR and oligo A synthetase/RNase L.	Virology	2007

1 - 50 of 53

Benjamin E Nilsson-Payant

Hanover Medical School

Career Start Year 2017

Number of shared co-authors 7

Stuart Weston

University of Maryland School of Medicine

Career Start Year 2014

Number of shared co-authors 19

Andreas S Puschnik

Stanford University School of Medicine

Career Start Year 2013

Number of shared co-authors 1

David Sachs

Icahn School of Medicine at Mount Sinai

Career Start Year 2013

Number of shared co-authors 8

Sebastian Giese

Institute of Virology, Freiburg University Medical Center, University of Freiburg

Career Start Year 2012

Number of shared co-authors 7

Maxime Chazal

CNRS UMR9, Institut Pasteur, Universite de Paris Cite

Career Start Year 2012

Number of shared co-authors 8

Brook E Heaton

Duke University School of Medicine

Career Start Year 2012

Number of shared co-authors 2

James Zengel

Stanford University School of Medicine

Career Start Year 2010

Number of shared co-authors 4

Jennifer Tisoncik-Go

Center for Innate Immunity and Immune Disease, University of Washington

Career Start Year 2009

Number of shared co-authors 3

Maria Teresa S??nchez-Aparicio

Icahn School of Medicine at Mount Sinai

Career Start Year 2009

Number of shared co-authors 29

Lisa Miorin

Icahn School of Medicine at Mount Sinai

Career Start Year 2008

Number of shared co-authors 34

Juan Ayllon

Icahn School of Medicine at Mount Sinai

Career Start Year 2007

Number of shared co-authors 15

Colm Atkins

Rutgers University

Career Start Year 2007

Number of shared co-authors 3

Amber M Smith

University of California san francisco

Career Start Year 2006

Number of shared co-authors 8

Nicholas S Heaton

Duke University School of Medicine

Career Start Year 2006

Number of shared co-authors 8

Amie J Eisfeld

Influenza Research Institute, University of Wisconsin-Madison

Career Start Year 2006

Number of shared co-authors 1

Chengjun Li

Harbin Veterinary Research Institute

Career Start Year 2005

Number of shared co-authors 3

Nolwenn Jouvenet

CNRS UMR9, Institut Pasteur, Universite de Paris Cite

Career Start Year 2003

Number of shared co-authors 8

Yaw Shin Ooi

Duke-NUS Medical School

Career Start Year 2003

Number of shared co-authors 4

Man-Seong Park

Korea University College of Medicine

Career Start Year 2001

Number of shared co-authors 7

Benjamin R tenOever

NYU Grossman School of Medicine

Career Start Year 2001

Number of shared co-authors 18

Birgit Bradel-Tretheway

Washington State University

Career Start Year 2000

Number of shared co-authors 0

Masato Hatta

Influenza Research Institute, University of Wisconsin-Madison

Career Start Year 2000

Number of shared co-authors 4

Ignacio Mena

Icahn School of Medicine at Mount Sinai

Career Start Year 1994

Number of shared co-authors 29

Ana Fernandez-Sesma

Icahn School of Medicine at Mount Sinai

Career Start Year 1993

Number of shared co-authors 30

Gabriele Neumann

Influenza Research Institute, University of Wisconsin-Madison

Career Start Year 1993

Number of shared co-authors 5

Matthew B Frieman

Center for Pathogen Research, University of Maryland School of Medicine

Career Start Year 1993

Number of shared co-authors 25

Yoshihiro Kawaoka

Influenza Research Institute, University of Wisconsin

Career Start Year 1979

Number of shared co-authors 6

Michael G Katze

University of Washington

Career Start Year 1978

Number of shared co-authors 6

Hans-Dieter Klenk

Institute of Virology, Philipps University

Career Start Year 1965

Number of shared co-authors 10

row(s) 1 - 30 of 30

Marie O Pohl

Institute of Medical Virology, University of Zurich

Co-authored papers 18

Adolfo Garc??a-Sastre

Icahn School of Medicine at Mount Sinai

Co-authored papers 12

Georg Kochs

Institute of Virology, Freiburg University Medical Center, University of Freiburg

Co-authored papers 10

Emilio Y??ng??ez

Roche Pharma Research and Early Development

Co-authored papers 7

Peter Palese

Icahn School of Medicine at Mount Sinai

Co-authored papers 6

Megan L Shaw

Icahn School of Medicine at Mount Sinai

Co-authored papers 6

Sumit K Chanda

The Scripps Research Institute

Co-authored papers 5

Sira C G??nther

Institute of Medical Virology, University of Zurichgrid.0.3

Co-authored papers 4

Balaji Manicassamy

University of Iowa

Co-authored papers 4

Paul D De Jesus

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 4

Renate K??nig

Paul-Ehrlich-Institut

Co-authored papers 3

Lars Pache

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 3

Dario Andenmatten

Institute of Medical Virology, University of Zurich

Co-authored papers 3

Randy A Albrecht

Icahn School of Medicine at Mount Sinai

Co-authored papers 3

Atsushi Inoue

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

Sharon E Frey

Saint Louis University School of Medicine

Co-authored papers 2

Rong Hai

University of California riverside

Co-authored papers 2

Judith G Alamares

Icahn School of Medicine at Mount Sinai

Co-authored papers 2

Yingyao Zhou

Genomics Institute of the Novartis Research Foundation

Co-authored papers 2

Quy Nguyen

University of California irvine

Co-authored papers 2

Ariel Rodriguez-Frandsen

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

Christopher F Basler

Icahn School of Medicine at Mount Sinai

Co-authored papers 2

Carles Mart??nez-Romero

Icahn School of Medicine at Mount Sinai

Co-authored papers 2

Kris M White

Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)

Co-authored papers 2

Laura Martin-Sancho

The Scripps Research Institute

Co-authored papers 1

Mila B Ortigoza

NYU Grossman School of Medicine

Co-authored papers 1

Qinshan Gao

Merck & Co., Inc.

Co-authored papers 1

Maria G Gonzalez

Center for Comparative Medicine and Surgery, Icahn School of Medicine at Mount Sinai

Co-authored papers 1

Sunnie M Yoh

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Doug Sanders

University of California san francisco

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators